A major goal of the Stroke Recovery and Rehabilitation Roundtable (SRRR) is to accelerate development of effective treatments to enhance stroke recovery beyond that expected to occur spontaneously or with current approaches. In this paper, we describe key issues for the next generation of stroke recovery treatment trials and present the Stroke Recovery and Rehabilitation Roundtable Trials Development Framework (SRRR-TDF). An exemplar (an upper limb recovery trial) is presented to demonstrate the utility of this framework to guide the GO, NO-GO decision-making process in trial development.
BernhardtJHaywardKSKwakkelG, et al.Agreed definitions and a shared vision for new standards in stroke recovery research: the Stroke Recovery and Rehabilitation Roundtable taskforce. Int J Stroke2017; 12: 444–450.
2.
BoydLAHaywardKSWardNS, et al.Biomarkers of stroke recovery: consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable (SRRR). Int J Stroke2017; 12: 480–493.
3.
WalkerMFHoffmannTCBradyMC, et al.Improving the development, monitoring and reporting of stroke rehabilitation research: consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable. Int J Stroke2017; 12: 472–449.
4.
KwakkelGLanninNBorschmannK, et al.Standardised measurement of sensorimotor recovery in stroke trials: consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable (SRRR). Int J Stroke2017; 12: 451–461.
5.
CorbettDCarmichaelSTMurphyTH, et al.Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable Translational Working Group. Int J Stroke2017; 12: 462–471.
6.
KrakauerJWCarmichaelST. Broken movement: the neurobiology of motor recovery after stroke, Cambridge: MIT Press, 2017.
LinDJFinklesteinSPCramerSC. New directions in treatments targeting stroke recovery. Stroke2018; 49: 3107–114.
9.
JeffersMSCorbettD. Synergistic effects of enriched environment and task-specific reach training on poststroke recovery of motor function. Stroke2018; 49: 1496–1503.
10.
MacLellanCLKeoughMBGranter-ButtonSChernenkoGAButtSCorbettD. A critical threshold of rehabilitation involving brain-derived neurotrophic factor is required for poststroke recovery. Neurorehabil Neural Repair2011; 25: 740–748.
11.
NudoRJMilikenGW. Reorganisation of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys. J Neurophysiol1996; 75: 144–149.
12.
LohseKRLangCEBoydLA. Is more better? Using meta-data to explore dose-response relationships in stroke rehabilitation. Stroke2014; 45: 2053–2058.
13.
SchneiderEJLanninNAAdaLSchmidtJ. Increasing the amount of usual rehabilitation improves activity after stroke: a systematic review. J Physiother2016; 62: 182–187.
14.
DalyJJMcCabeJPHolcombJMonkiewiczMGansenJPundikS. Long-dose intensive therapy is necessary for strong, clinically significant, upper limb functional gains and retained gains in severe/moderate chronic stroke. Neurorehabil Neural Repair2019; 33: 523–537.
15.
WardNSBranderFKellyK. Intensive upper limb neurorehabilitation in chronic stroke – the Queen Square Programme. J Neurol Neurosurg Psychiatry2019; 90: 498–506.
16.
DiteWLangfordZNCummingTBChurilovLBlennerhassettJMBernhardtJ. A Phase 1 exercise dose escalation study for stroke survivors with impaired walking. Int J Stroke2015; 10: 1051–1056.
17.
ColucciEClarkALangCEPomeroyVM. A rule-based, dose-finding design for use in stroke rehabilitation research: methodological development. Physiotherapy2017; 103: 414–422.
18.
PollockAFarmerSEBradyMC, et al.Interventions for improving upper limb function after stroke. Cochrane Database Syst Rev2014; 11: CD010820.
19.
JeffersMSKarthikeyanSGomez-SmithM, et al.Does stroke rehabilitation really matter? Part B: an algorithm for prescribing an effective intensity of rehabilitation. Neurorehabil Neural Repair2018; 32: 73–83.
20.
LangCELohseKRBirkenmeijerRL. Dose and timing in neurorehabilitation: prescribing motor therapy after stroke. Curr Opin Neurol2015; 28: 549–555.
21.
HaywardKSBarkerRNCarsonRGBrauerSG. The effect of altering a single component of a rehabilitation programme on the functional recovery of stroke patients: a systematic review and meta-analysis. Clin Rehab2014; 28: 107–117.
22.
BorschmannKHaywardKSRaffeltAChurilovLKramerSFBernhardtJA. Rationale for intervention and dose is lacking in stroke recovery trials: a systematic review. Stroke Res Treat2018; 2018: 8087372.
23.
WintersCHeymansMWvan WegenEEKwakkelG. How to design clinical rehabilitation trials for the upper paretic limb early post stroke?. Trials2016; 17: 468.
24.
SimpsonLHaywardKSMcPeakeMEngJJ. An updated distribution of upper limb weakness post stroke: are fewer people experiencing arm weakness today?. Int J Stroke2018; 13: 41.
25.
StinearCMByblowWDAckerleySJSmithMCBorgesVMBarberPA. PREP2: a biomarker-based algorithm for predicting upper limb function after stroke. Ann Clin Transl Neurol2017; 4: 811–820.
26.
BiernaskieJChernenkoGCorbettD. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci2004; 24: 1245–1254.
27.
FirthNBarkerRNHaywardKSBernhardtJBellinganMGunnarssonR. Safety and efficacy of recovery-promoting drugs for motor function after stroke: a systematic review of randomized controlled trials. J Rehabil Med2019; 51: 319–330.
28.
MeadGEHsiehCFLeeR, et al.Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev2012; 11: CD009286.
29.
Simonetta-MoreauM. Non-invasive brain stimulation (NIBS) and motor recovery after stroke. Ann Phys Rehabil Med2014; 57: 530–542.
30.
PallmannPBeddingAWChoodari-OskooeiB, et al.Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Med2018; 16: 29.
31.
BrattonDJPhillipsPPJParmarMKB. A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis. BMC Med Res Methodol2013; 13: 139.
32.
BhattDLMehtaC. Adaptive designs for clinical trials. New Eng J Med2016; 375: 65–74.
33.
FaganSCWallerJLNicholsFT, et al.Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke2010; 41: 2283–2287.
34.
RenfroLASargentDJ. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples. Ann Oncol2017; 28: 34–43.
HoffmannTCGlasziouPPBoutronI, et al.Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ2014; 348: 1687.
37.
Stroke Therapy Academic Industry R. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke1999; 30: 2752–2758.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
